Ksg 504
Code | Size | Price |
---|
TAR-T32425-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T32425-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T32425-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Ksg 504 has superior selectivity and affinity to CCK-A receptors and derived from proglumide.
CAS:
137005-17-5
Formula:
C31H49N5O8S
Molecular Weight:
651.82
Purity:
0.98
SMILES:
N[C@@H](CCCNC(N)=N)C(O)=O.CCCCCN(CCCOC)C(=O)[C@@H](CCC(O)=O)CS(=O)(=O)c1ccc2ccccc2c1
References
1. Okumura Y, Inoue H, Fujiyama Y, Bamba T. Effects of short-term administration of the CCK receptor antagonist, KSG-504, on regeneration of pancreatic acinar cells in acute pancreatitis in rats. J Gastroenterol. 1995 Aug;30(4):493-9. PubMed PMID: 7550860.
2. Tak?cs T, Czak? L, J?rmay K, Farkas G Jr, M?ndi Y, Lonovics J. Cytokine level changes in L-arginine-induced acute pancreatitis in rat. Acta Physiol Hung. 1996;84(2):147-56. PubMed PMID: 9046361.
3. Moriyoshi Y, Shiratori K, Takeuchi T, Watanabe S. A new CCK-A antagonist, KSG-504, administered intraduodenally, inhibits pancreatic secretion in rats. Pancreas. 1994 Mar;9(2):225-9. PubMed PMID: 8190724.
4. Yamazaki Y, Takeda H, Akahane M, Tsubaki A, Ajisawa Y. [Behavioral studies of KSG-504, a new CCK-A receptor antagonist]. Nihon Yakurigaku Zasshi. 1996 Jan;107(1):21-31. Japanese. PubMed PMID: 8720295.